𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Brief Report: CD109 Overexpression Ameliorates Skin Fibrosis in a Mouse Model of Bleomycin-Induced Scleroderma

✍ Scribed by Vorstenbosch, Joshua; Al-Ajmi, Hasan; Winocour, Sebastian; Trzeciak, Alissa; Lessard, Lucie; Philip, Anie

Book ID
121717769
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
755 KB
Volume
65
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trichostatin A prevents the accumulation
Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis
✍ Lars C. Huber; Jörg H. W. Distler; Falk Moritz; Hossein Hemmatazad; Thomas Hause 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 2 views

## Abstract ## Objective Tissue fibrosis is a hallmark compromising feature of many disorders. In this study, we investigated the antifibrogenic effects of the histone deacetylase inhibitor trichostatin A (TSA) on cytokine‐driven fibrotic responses in vitro and in vivo. ## Methods Skin fibroblas

α-melanocyte–stimulating hormone suppres
α-melanocyte–stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: Melanocortin peptides as a novel treatment strategy for scleroderma?
✍ Agatha Kokot; Anca Sindrilaru; Meinhard Schiller; Cord Sunderkötter; Claus Kerkh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 778 KB

## Abstract ## Objective Recently, we found that human dermal fibroblasts (HDFs) express melanocortin 1 receptors (MC‐1R) that bind α‐melanocyte–stimulating hormone (α‐MSH). In search of novel therapies for scleroderma (systemic sclerosis [SSc]), we used the bleomycin (BLM) model to investigate th